← All trials
NCT00273455
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2006
- Primary completion
- —
- Completion date
- May 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 34
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- PRN Pharmacuetical Research Network, LLCLead sponsor
- Houston Eye AssociatesOverall official - principal investigator
- Glaucoma Consultants & Center for Eye Research, PAOverall official - principal investigator
- PRN Pharmacuetical Research Network, LLCStudy director
- University of RochesterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.